SuperworthInfuSystem market cap INFU
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Oct 23, 2026
- $277.6M
- Highest close in our data
- $460M
- Apr 2021
InfuSystem is worth $277.6M at the close on Oct 23, 2026, at $13.94 a share.
That is up 34% over the last year and down 19% over five years.
Its highest close in our data was $460M in Apr 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $277.6M | $153.3M | $277.6M | +52% |
| 2025 | $182.2M | $101.9M | $220.2M | +5% |
| 2024 | $173.1M | $124.5M | $209.9M | −22% |
| 2023 | $223.3M | $144.2M | $234.3M | +25% |
| 2022 | $179.3M | $139.3M | $333.7M | −49% |
| 2021 | $351.7M | $264.7M | $460M | −7% |
| 2020 | $380M | $119.3M | $384.3M | +133% |
| 2019 | $163.1M | $66.8M | $171.4M | +147% |
| 2018 | $66.1M | $50.1M | $80.8M | +26% |
| 2017 | $52.4M | $29.6M | $55.8M | −9% |
| 2016 | $57.8M | $40.7M | $81.2M | −15% |
| 2015 | $68M | $58.8M | $73.6M | −1% |
| 2014 | $68.4M | $47.3M | $89.4M | +44% |
| 2013 | $47.5M | $28.5M | $47.9M | +47% |
| 2012 | $32.3M | $31M | $47.6M | −6% |
| 2011 | $34.2M | $19.4M | $39.3M | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest InfuSystem's size, closest first, today.
| Company | Market cap |
|---|---|
| INFUInfuSystem | $277.6M |
| UTMDUtah Medical Products | $236.3M |
| EMBCEmbecta | $380.2M |
| PDEXPro DEX | $199.3M |
| TCMDTactile Systems Technology | $535.5M |
| MDXGMimedx | $569.9M |
| MOVMovado | $701.9M |
| KEQUKewaunee Scientific | $94.9M |
| IRMDIradimed | $1.1B |
| STAAStaar Surgical | $1.1B |
| BVSBioventus | $1.3B |
| Peer median | $552.7M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on InfuSystem
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.